Enanta Pharmaceuticals Inc (ENTA)

[semi_infinite]

Thanks for the well thought out comments. I see a dozen players in the HBV inhibitor space including ENTA and three players in the HBV immunology space. Is ENTA the odds on favorite in the inhibitor space and do you see some possible synergy with T-cell approaches resulting in combos there?